A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapyJohn R. North, Oreola Donini, Annett Rozek et al.|Journal of Biotechnology|2016Cited by 30
Critical Residues at the Ly49 Natural Killer Receptor’s Homodimer Interface Determine Functional Recognition of m157, a Mouse Cytomegalovirus MHC Class I-Like ProteinAgnieszka Kielczewska, Silvia M. Vidal|The Journal of Immunology|2007Cited by 28